PhD Monika Savarin

PhD Monika Savarin
no.: 35355 source: ARIS

researcher – active in research organisation
  monika.savarinat signlabena.si
Edit
Research activity

Code Science Field Subfield
3.00.00  Medical sciences     
3.04.00  Medical sciences  Oncology   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
79.57
A''
0
A'
48.13
A1/2
71.35
CI10
215
CImax
25
h10
10
A1
0.29
A3
0
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 24  327  175  7.29 
Scopus 22  370  213  9.68 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
2nd cycle master's degree      SI University of Ljubljana, Biotechnical Faculty 2012 
Doctoral degree  Ph. D.   Biomedicine  SI University of Ljubljana, Faculty of Medicine 2017 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:50%)  LABENA trgovina, svetovanje in proizvodnja laboratorijske opreme d.o.o. (Slovene)  Labena raziskave in razvoj (Slovene)  8/1/2022    Researcher  Researcher 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. Z3-1873  A novel vascular targeted approach based on gene therapy silencing two independent signaling pathways in combination with radiotherapy   7/1/2019 - 7/31/2022  PhD Monika Savarin   65 
2. J3-8202  Spremljanje imunskega odziva v realnem času po in situ vakcinaciji z elektrokemoterapijo in pridruženo gensko terapijo z interlevkinom-12 (Slovene)   5/1/2017 - 4/30/2020  PhD Maja Čemažar   3,811 
3. J3-7460  Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model   1/1/2016 - 12/31/2018  PhD Primož Strojan   4,561 
4. J3-6796  Translacijska onkologija: razvoj in validacija imunsko genske terapije z interleukinom-12 v kombinaciji s kirurgijo pri oralnih in kožnih tumorjih psov (Slovene)   7/1/2014 - 6/30/2017  PhD Maja Čemažar   5,190 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2022 - 12/31/2027 PhD Gregor Serša   4,393 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2015 - 12/31/2021 PhD Gregor Serša   3,528 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   1/1/2009 - 12/31/2014 PhD Gregor Serša   4,296 
Confirmation required
Views history
Favourite